$CYAB SEC Filings

Filed On	Filing
16 Oct 2026	EFFECT
16 Oct 2026	Proxy statement: annual meeting on November 10, 2026 CEO pay $374K, down 1.8%
08 Oct 2026	REGISTRATION STATEMENT
05 Oct 2026	PROXY STATEMENT
22 Sep 2026	SCHEDULE 13G
22 Sep 2026	SCHEDULE 13G
18 Sep 2026	EFFECT
16 Sep 2026	AMENDMENT NO. 2 TO FORM S-1
10 Sep 2026	8-K: Unregistered Sales of Equity Securities; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year As previously disclosed, on July 9, 2026, Cyabra, Inc. (the “Company”) entered into an exchange agreement (the “Exchange Agreement”) with Alpha Capital Anstalt (the “Holder”) that holds the outstanding Series C Convertible Preferred Stoc...
03 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
01 Sep 2026	AMENDMENT NO. 1 TO FORM S-1
17 Aug 2026	REGISTRATION STATEMENT
13 Aug 2026	QUARTERLY REPORT
11 Aug 2026	Proxy statement: special meeting on September 2, 2026
31 Jul 2026	PRELIMINARY PROXY STATEMENT
31 Jul 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
31 Jul 2026	REGISTRATION STATEMENT
20 Jul 2026	D
13 Jul 2026	Form 4: Daar Yossef, Director Received 53,650 shares as a grant or award ($23.3K) · Acquired 107,300 Common Stock Warrants (right to buy) (Open Market Purchase) ($51K)
13 Jul 2026	Form 4: Flanagan James Francis, Director Received 114,940 shares as a grant or award ($50K) · Acquired 229,880 Common Stock Warrants (right to buy) (Open Market Purchase) ($109K)

Comments